Ian S. Hagemann
Ian S. Hagemann
Assistant Professor, Dept. of Pathology and Immunology, Washington University in St. Louis
Verified email at path.wustl.edu
Title
Cited by
Cited by
Year
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T reg cells
A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ...
Nature 475 (7355), 226-230, 2011
7182011
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
GT Motz, SP Santoro, LP Wang, T Garrabrant, RR Lastra, IS Hagemann, ...
Nature medicine 20 (6), 607, 2014
3642014
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis
WT Hwang, SF Adams, E Tahirovic, IS Hagemann, G Coukos
Gynecologic oncology 124 (2), 192-198, 2012
3422012
Validation of a next-generation sequencing assay for clinical molecular oncology
CE Cottrell, H Al-Kateb, AJ Bredemeyer, EJ Duncavage, DH Spencer, ...
The Journal of molecular diagnostics 16 (1), 89-105, 2014
1512014
Clinical next‐generation sequencing in patients with non–small cell lung cancer
IS Hagemann, S Devarakonda, CM Lockwood, DH Spencer, K Guebert, ...
Cancer 121 (4), 631-639, 2015
1422015
Geometric Magnetic Frustration in Ba2Sn2Ga3ZnCr7O22: A Two-Dimensional Spinel Based Kagomé Lattice
IS Hagemann, Q Huang, XPA Gao, AP Ramirez, RJ Cava
Physical review letters 86 (5), 894-897, 2001
1392001
High-throughput detection of prostate cancer in histological sections using probabilistic pairwise Markov models
JP Monaco, JE Tomaszewski, MD Feldman, I Hagemann, M Moradi, ...
Medical image analysis 14 (4), 617-629, 2010
1352010
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor
E Lanitis, M Poussin, IS Hagemann, G Coukos, R Sandaltzopoulos, ...
Molecular Therapy 20 (3), 633-643, 2012
1292012
Risk of occult malignancy in morcellated hysterectomy: a case series
IS Hagemann, AR Hagemann, VA LiVolsi, KT Montone, CS Chu
International journal of gynecological pathology 30 (5), 476-483, 2011
672011
Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels
E Lanitis, D Dangaj, IS Hagemann, DG Song, A Best, R Sandaltzopoulos, ...
Plos one 7 (11), 2012
642012
Synthesis, structure and physical properties of Ru ferrites: BaMRu5O11 (M= Li and Cu) and BaM′2Ru4O11 (M′= Mn, Fe and Co)
ML Foo, Q Huang, JW Lynn, WL Lee, T Klimczuk, IS Hagemann, NP Ong, ...
Journal of Solid State Chemistry 179 (2), 563-572, 2006
522006
Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy
IS Hagemann, CE Cottrell, CM Lockwood
Cancer genetics 206 (12), 420-431, 2013
512013
Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers
B Zhang, XY Xing, J Li, RF Lowdon, Y Zhou, N Lin, B Zhang, V Sundaram, ...
BMC genomics 15 (1), 868, 2014
442014
Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
R Uppaluri, P Zolkind, T Lin, B Nussenbaum, RS Jackson, J Rich, ...
Journal of Clinical Oncology 35 (15_suppl), 6012-6012, 2017
412017
Geometric magnetic frustration in olivines
IS Hagemann, PG Khalifah, AP Ramirez, RJ Cava
Physical Review B 62 (2), 771-774, 2000
412000
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides
KE Sufficool, CM Lockwood, HJ Abel, IS Hagemann, JA Schumacher, ...
Journal of the American Academy of Dermatology 73 (2), 228-236. e2, 2015
402015
A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancer
CX Ma, V Suman, MP Goetz, D Northfelt, ME Burkard, F Ademuyiwa, ...
Clinical Cancer Research 23 (22), 6823-6832, 2017
362017
Molecular testing in breast cancer: a guide to current practices
IS Hagemann
Archives of pathology & laboratory medicine 140 (8), 815-824, 2016
352016
A retrospective comparison of 2 methods of intraoperative margin evaluation during partial nephrectomy
IS Hagemann, JS Lewis Jr
The Journal of urology 181 (2), 500-505, 2009
332009
The ovarian cancer chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28–costimulated T cells prepared for adoptive therapy
E Zsiros, P Duttagupta, D Dangaj, H Li, R Frank, T Garrabrant, ...
Clinical Cancer Research 21 (12), 2840-2850, 2015
312015
The system can't perform the operation now. Try again later.
Articles 1–20